Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

13.82
Delayed Data
As of 4:00pm ET
 +0.37 / +2.75%
Today’s Change
10.43
Today|||52-Week Range
45.20
-8.42%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close13.45
Today’s open13.48
Day’s range13.33 - 13.92
Volume529,187
Average volume (3 months)546,036
Market cap$583.9M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+7.56%
Earnings growth (this year)-18.91%
Earnings growth (next 5 years)--
Revenue growth (last year)+261.96%
P/E ratioNM
Price/Sales1,973.06
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
CTMXCytomX Therapeutics ...-0.34-2.12%
PRTKParatek Pharmaceutic...-0.20-0.92%
ENTAEnanta Pharmaceutica...+0.69+2.22%
ACIUAC Immune Ltd0.000.00%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$330.7K
Annual profit (last year)-$116.4M
Net profit margin-35,205.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts